Expansion Momentum Cambrex is actively expanding across the US and Europe with large-scale API manufacturing plants and facility upgrades in Iowa, Milan, and Coffeyville, indicating ongoing capacity growth and potential for multi-site outsourcing opportunities.

Large-Scale API Recent investments and completed studies point to a focus on large-scale API production in Charles City, Iowa, presenting sales opportunities for customers needing scalable manufacturing capacity and robust supply continuity.

End-to-End CDMO With capabilities spanning drug substance development, manufacturing, analytical services, and IND enabling activities, Cambrex can be positioned as a single-source partner for clients seeking streamlined development to commercial production.

Technical Expertise Specialized technologies such as continuous flow, highly potent APIs, solid-state science, and peptide synthesis offer entry points for customers in complex small-molecule and peptide programs seeking advanced manufacturing solutions.

Global Footprint A broad North America and Europe footprint combined with a multi-site expansion strategy suggests opportunities to support multinational brands with regional manufacturing hubs and contingency supply planning.